Comparison of Tolbutamide and Insulin Pre-Treatment Prior to Alloxan Induced Diabetes
Robert C. Meade, H. M. Klitgaard
Abstract
Robert C. Meade, H. M. Klitgaard
Abstract
1) Starvation or glucose plus tolbutamide potentiates the diabetogenic activity of alloxan with increased mortality. 2) Glucose alone or glucose plus insulin protects against alloxan diabetes. 3) Different results obtained with insulin or tolbutamide cannot be explained on the basis of liver glycogen content, blood glucose, or theoretical status of pancreatic activity at time of alloxan injection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
1) Starvation or glucose plus tolbutamide potentiates the diabetogenic activity of alloxan with increased mortality. 2) Glucose alone or glucose plus insulin protects against alloxan diabetes. 3) Different results obtained with insulin or tolbutamide cannot be explained on the basis of liver glycogen content, blood glucose, or theoretical status of pancreatic activity at time of alloxan injection.
Key concepts: Tolbutamide, Alloxan, Internal medicine, Endocrinology, Glycogen, Insulin, Diabetes mellitus, Starvation